Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Bioinformatics investigation of the prognostic value and mechanistic role of CD9 in glioma.

Scientific reports - 18 Oct 2024

Jiang Jing, Jiang Bo, Li Wen-Bin

Abstract excerpt

In recent years, CD9 has been extensively studied as a potential biomarker for cancer. However, the biological role of CD9 in gliomas remains unclear. This study investigates the function of CD9 in gliomas and its molecular mechanisms. Utilizing pan-cancer analysis with TCGA, CGGA, and GEO databases, differential expression of CD9 was observed in 11 tumor types within the TCGA cohort, and it was associated with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Brain Neoplasms
Share to Cell Line, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Computational Biology

Share to Gene Expression Regulation, Neoplastic

Share to Glioma

Share to Mutation

Share to Prognosis

Source

Open in PubMed Open full text

Identifiers

PMID: 39424846
DOI: 10.1038/s41598-024-74109-w
PMCID: PMC11489571

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Bioinformatics investigation of the prognostic value and mechanistic role of CD9 in glioma.PMID 39424846Read ↗

Siglec-9, a Putative Immune Checkpoint Marker for Cancer Progression Across Multiple Cancer TypesSemantic proximity Read ↗

CD93 is Associated with Glioma-related Malignant Processes and Immunosuppressive Cell Infiltration as an Inspiring Biomarker of Survivance.Semantic proximity Read ↗

Siglec10 as an Immunosuppressive and Tumorgenesis Signature for Prediction of Survival Prognosis in GliomasSemantic proximity Read ↗

Siglec10 as an Immunosuppressive and Tumorgenesis Signature for Prediction of Survival Prognosis in GliomasSemantic proximity Read ↗

Identification of CD73 as a Novel Biomarker Encompassing the Tumor Microenvironment, Prognosis, and Therapeutic Responses in Various CancersSemantic proximity Read ↗

CD99 is a potential diagnostic and immunological biomarker in pan-cancerSemantic proximity Read ↗

Expression Analysis, Molecular Characterization and Prognostic Evaluation on <i>TMED4</i> and <i>TMED9</i> Gene Expression in GliomaSemantic proximity Read ↗

Multi-omics analyses of CD276 in pan-cancer reveals its clinical prognostic value in glioblastoma and other major cancer typesSemantic proximity Read ↗

CD9, a tetraspanin target for cancer therapy?Semantic proximity Read ↗

CD13 expression affects glioma patient survival and influences key functions of human glioblastoma cell lines in vitroSemantic proximity Read ↗

SLC12A9 is an immunological and prognostic biomarker for glioma.Semantic proximity Read ↗

Molecular and clinical characterization of CD163 expression via large-scale analysis in gliomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.